Heavy Pharmaceutical Holdings announced that Chongqing Pharmaceutical (Group) Co., Ltd., a holding subsidiary of the company, recently received the “Drug Registration Certificate” approved and issued by the State Drug Administration. Drug name: Tofacib citrate tablets.
重药控股：控股子公司获得药品注册证书
Heavy Pharmaceutical Holdings: The holding subsidiary obtained a drug registration certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.